Triptan better than ergot drug for migraine
|
Tweet
|
|
Dihydroergotamine, an anti-migraine drug, is not as effective as sumatriptan as a single agent for the treatment of acute migraine headache, according to results of a systematic review of published studies. However, dihydroergotamine works better when it is combined with an anti-nausea drug.
Many therapies are used in the treatment of acute migraine headache, with little agreement on effectiveness, Dr. Brain H. Rowe, of the University of Alberta, Edmonton, and colleagues explain in a report in the Annals of Emergency Medicine.
Dihydroergotamine is considered a “second-line” agent for migraine, but data on its effectiveness and tolerability are mixed.
Rowe and colleagues examined the effectiveness of dihydroergotamine in reducing pain, nausea, and relapse for episodes of acute migraine. They reviewed 11 randomized controlled studies that compared dihydroergotamine (alone or in combination with an antiemetic) with inactive placebo or any other common migraine therapy.
Results of these studies did not demonstrate a significant benefit of dihydroergotamine over other treatments. Patients on dihydroergotamine experienced nausea almost four times more often than those on the other therapies.
The evidence suggests that dihydroergotamine is “not as effective as” sumatriptan or phenothiazines as a single agent for treatment of acute migraine headache, the authors write. However, when given with an antiemetic, dihydroergotamine appears to be as effective as other commonly used anti-migraine agents, they report.
Given its nonnarcotic properties, dihydroergotamine combined with an antiemetic should be considered as effective initial therapy, they conclude.
SOURCE: Annals of Emergency Medicine, April 2005.
Revision date: June 20, 2011
Last revised: by Andrew G. Epstein, M.D.
| RELATED STORIES: | ||
| Comments | [ + Post Your Own ] |
Now you're in the public comment zone. What follows is not Armenian Medical Network's stuff; it comes from other people and we don't vouch for it. A reminder: By using this Web site you agree to accept our Terms of Service. Click here to read the Rules of Engagement.
There are no comments for this entry yet. [ + Comment here + ]
We are pleased to let readers post comments about an article. Please increase the credibility of your post by including your full name and email.
All comments are reviewed by our editors before they are posted on the site. Just keep it clean, kids.
- Full Story - - »»»
New plan to cut the fat of the military
- Full Story - - »»»
EU wants more medical device controls after PIP scare
- Full Story - - »»»
Optimism about heart risks may be a good thing
- Full Story - - »»»
Study shows fainting factor in cardiac arrests
- Full Story - - »»»
Teen pregnancy, abortion rates at record low, study says
- Full Story - - »»»
Think you can’t get pregnant? Try again, study says
- Full Story - - »»»

